Rapid Micro Biosystems, Inc. (RPID) has a negative trailing P/E of -2.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -47.79%.
Criteria proven by this page:
Overall SharesGrow Score: 48/100 with 3/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2019 | -40.1 | 0.00 | -1,170.67 | 51.40 | - |
| 2020 | -22.3 | -0.18 | 33.34 | 51.47 | - |
| 2021 | -6.0 | -0.10 | 2.00 | 18.99 | - |
| 2022 | -0.8 | 0.03 | 0.29 | 2.80 | - |
| 2023 | -0.6 | 0.04 | 0.27 | 1.41 | - |
| 2024 | -0.8 | 0.07 | 0.52 | 1.40 | - |
| 2025 | -2.7 | 0.99 | 3.90 | 3.86 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2019 | $-0.53 | $16.51M | $-21.17M | -128.2% |
| 2020 | $-0.96 | $16.08M | $-37.08M | -230.6% |
| 2021 | $-1.77 | $23.23M | $-73.52M | -316.5% |
| 2022 | $-1.43 | $17.13M | $-60.81M | -354.9% |
| 2023 | $-1.22 | $22.52M | $-52.47M | -233% |
| 2024 | $-1.08 | $28.05M | $-46.89M | -167.2% |
| 2025 | $-1.05 | $33.59M | $-47.12M | -140.3% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.92 | $-0.96 – $-0.88 | $39.23M | $38.5M – $39.92M | 2 |
| 2027 | $-0.82 | $-0.84 – $-0.80 | $46.45M | $45.59M – $47.27M | 2 |
| 2028 | $-0.58 | $-0.59 – $-0.57 | $62.3M | $61.14M – $63.4M | 1 |
| 2029 | $-0.47 | $-0.48 – $-0.46 | $74.7M | $73.31M – $76.02M | 1 |
